Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease
- 1 October 2001
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (4) , S14-S19
- https://doi.org/10.1053/ajkd.2001.27384
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- LDL Size and Risk of Coronary Heart Disease in Elderly Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Endothelial function in proteinuric renal diseaseKidney International, 1999
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.Journal of Clinical Investigation, 1998
- Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease MortalityArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Glycation and oxidation: A role in the pathogenesis of atherosclerosisThe American Journal of Cardiology, 1993
- Low-density lipoprotein subclasses and risk of coronary artery diseaseCurrent Opinion in Lipidology, 1991
- Transient changes of serum lipoprotein(a) as an acute phase proteinAtherosclerosis, 1989